94.17
price down icon0.16%   -0.115
 
loading

Revvity Inc Aktie (RVTY) Neueste Nachrichten

pulisher
11:38 AM

Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook - Reuters

11:38 AM
pulisher
11:32 AM

Evercore ISI Adjusts Price Target on Revvity to $116 From $125 - marketscreener.com

11:32 AM
pulisher
10:47 AM

Biotech Firm Revvity Reports Better-Than-Expected Earnings - Investopedia

10:47 AM
pulisher
09:53 AM

Revvity's Steady Demand Lifts Q1 Results Above Expectations - Finimize

09:53 AM
pulisher
09:48 AM

Revvity Q1 Earnings Surpass Street Estimates, Investors Cheer 2025 Revised Revenue Guidance - MSN

09:48 AM
pulisher
09:30 AM

Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Nasdaq

09:30 AM
pulisher
09:14 AM

Life Science Tools Maker Revvity Delivers Strong Q1 Earnings Despite Evolving Macroeconomic Backdrop - Benzinga

09:14 AM
pulisher
08:33 AM

Revvity (RVTY) Surpasses Q1 Estimates and Updates 2025 Outlook - GuruFocus

08:33 AM
pulisher
07:54 AM

Revvity: Q1 Earnings Snapshot - Greenwich Time

07:54 AM
pulisher
07:52 AM

Revvity, Inc. (RVTY) Implements Majority Voting Standard Followi - GuruFocus

07:52 AM
pulisher
07:49 AM

Revvity beats quarterly estimates on steady demand for medical equipment - MSN

07:49 AM
pulisher
07:15 AM

Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance

07:15 AM
pulisher
06:57 AM

Revvity Announces Financial Results for the First Quarter of 202 - GuruFocus

06:57 AM
pulisher
06:53 AM

Revvity beats Q1 estimates, shares jump 4% By Investing.com - Investing.com Nigeria

06:53 AM
pulisher
06:48 AM

Revvity (RVTY) Exceeds Q1 Revenue Expectations with Strong Perfo - GuruFocus

06:48 AM
pulisher
06:30 AM

REVVITY Earnings Results: $RVTY Reports Quarterly Earnings - Nasdaq

06:30 AM
pulisher
06:29 AM

Revvity beats Q1 estimates, shares jump 4% - Investing.com Australia

06:29 AM
pulisher
06:14 AM

(RVTY) Revvity Expects Full-Year 2025 Revenue Range $2.83B$2.87B, vs. FactSet Est of $2.83B - marketscreener.com

06:14 AM
pulisher
06:00 AM

Revvity Announces Financial Results for the First Quarter of 2025 - Business Wire

06:00 AM
pulisher
Apr 27, 2025

Revvity (RVTY) Q1 Earnings Report Preview: What To Look For - The Globe and Mail

Apr 27, 2025
pulisher
Apr 27, 2025

Revvity’s Quarterly Earnings Preview: What You Need to Know - MSN

Apr 27, 2025
pulisher
Apr 26, 2025

Segmental Performance to Drive RVTY's Q1 Earnings: Is a Beat Likely? - MSN

Apr 26, 2025
pulisher
Apr 25, 2025

Why Revvity (RVTY) Could Beat Earnings Estimates Again - Yahoo Finance

Apr 25, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

Calculating The Fair Value Of Revvity, Inc. (NYSE:RVTY) - simplywall.st

Apr 25, 2025
pulisher
Apr 25, 2025

Earnings Preview For Revvity - Benzinga

Apr 25, 2025
pulisher
Apr 24, 2025

Revvity Keeps Quarterly Dividend at $0.07 a Share, Payable August 8 to Holders of Record July 18 - marketscreener.com

Apr 24, 2025
pulisher
Apr 24, 2025

Lobbying Update: $30,000 of REVVITY INC. lobbying was just disclosed - Nasdaq

Apr 24, 2025
pulisher
Apr 24, 2025

Revvity Board Declares Quarterly Dividend - Business Wire

Apr 24, 2025
pulisher
Apr 24, 2025

Revvity Board Declares Quarterly Dividend | RVTY Stock News - GuruFocus

Apr 24, 2025
pulisher
Apr 24, 2025

Revvity Continues Steady Dividend Program: $0.07 Per Share Coming This August - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Revvity to Unveil VivoJect Image-guided Injection System at AACR - Genetic Engineering and Biotechnology News

Apr 24, 2025
pulisher
Apr 23, 2025

Watchmaker Genomics and Revvity Team to Automate and Streamline NGS Library Preparation - Genetic Engineering and Biotechnology News

Apr 23, 2025
pulisher
Apr 23, 2025

Revvity’s Quarterly Earnings Preview: What You Need To Know - Barchart.com

Apr 23, 2025
pulisher
Apr 22, 2025

High Content Screening and Imaging Market Set for 8.4% CAGR Through 2029 - GlobeNewswire Inc.

Apr 22, 2025
pulisher
Apr 22, 2025

Revvity (RVTY) Price Target Cut by Baird Ahead of Q1 Results | R - GuruFocus

Apr 22, 2025
pulisher
Apr 22, 2025

Revvity Fuels the Future of Cancer Science with New Research Solutions - Business Wire

Apr 22, 2025
pulisher
Apr 21, 2025

Assessing Revvity: Insights From 6 Financial Analysts - Benzinga

Apr 21, 2025
pulisher
Apr 21, 2025

Earnings Preview: Revvity (RVTY) Q1 Earnings Expected to Decline - Yahoo Finance

Apr 21, 2025
pulisher
Apr 21, 2025

Revvity (RVTY) Price Target Cut by Baird Ahead of Q1 Results | RVTY Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 16, 2025

Bernstein Adjusts Price Target on Revvity to $120 From $140, Maintains Market Perform Rating - marketscreener.com

Apr 16, 2025
pulisher
Apr 16, 2025

Revvity price target lowered to $120 from $140 at Bernstein - TipRanks

Apr 16, 2025
pulisher
Apr 16, 2025

Lab equipment giant ensnared in sprawling $300M fraud case over failed testing tools - Crain's Chicago Business

Apr 16, 2025
pulisher
Apr 16, 2025

Revvity (RVTY) Faces Price Target Cut Amid Funding Concerns | RV - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

Ex-Dividend Reminder: Revvity, Dime Community Bancshares and First Busey - Nasdaq

Apr 15, 2025
pulisher
Apr 15, 2025

What Is Revvity, Inc.'s (NYSE:RVTY) Share Price Doing? - Yahoo Finance

Apr 15, 2025
pulisher
Apr 15, 2025

BofA Reduces Revvity (RVTY) Price Target Amid Policy Challenges - GuruFocus

Apr 15, 2025
pulisher
Apr 14, 2025

BofA Securities Cuts Price Target on Revvity to $116 From $143, Maintains Buy Rating - MarketScreener

Apr 14, 2025
pulisher
Apr 14, 2025

BofA Reduces Revvity (RVTY) Price Target Amid Policy Challenges | RVTY Stock News - GuruFocus

Apr 14, 2025
pulisher
Apr 11, 2025

KeyBanc Lowers Price Target on Revvity to $135 From $145 - MarketScreener

Apr 11, 2025
pulisher
Apr 11, 2025

Choosing a flexible digital platform for drug discovery - Scientific Computing World

Apr 11, 2025
pulisher
Apr 11, 2025

Barclays Adjusts Revvity (RVTY) Price Target Ahead of Q1 Earnings | RVTY Stock News - GuruFocus

Apr 11, 2025
pulisher
Apr 10, 2025

Barclays Adjusts Price Target on Revvity to $110 From $140 - MarketScreener

Apr 10, 2025
pulisher
Apr 09, 2025

KeyBanc maintains Overweight rating on Revvity stock at $145 target - Investing.com Australia

Apr 09, 2025
pulisher
Apr 09, 2025

KeyBanc maintains Overweight rating on Revvity stock at $145 target By Investing.com - Investing.com South Africa

Apr 09, 2025
diagnostics_research LH
$230.29
price up icon 0.90%
diagnostics_research DGX
$175.19
price up icon 0.25%
$153.49
price up icon 0.60%
diagnostics_research WAT
$343.13
price up icon 1.02%
diagnostics_research MTD
$1,085.93
price up icon 1.48%
diagnostics_research IQV
$152.00
price up icon 0.80%
Kapitalisierung:     |  Volumen (24h):